Completed NA INTERVENTIONAL 2-arm NCT01086839

Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis

Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis. A Multicenter, Randomized, Double-blind, Placebo-controlled, Prospective Clinical Trial

Sponsor: University of Jena

Conditions Cystic Fibrosis Rhinosinusitis

Interventions sodium chloride 0,9% sodium chloride 6%

Updated 6 times since 2017 Last updated: Nov 28, 2014 Started: Mar 31, 2010 Primary completion: Apr 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01086839, this NA trial focuses on Cystic Fibrosis and Rhinosinusitis and remains completed. Sponsored by University of Jena, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Jena

Data source: University of Jena

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Berlin, Germany , Frankfurt am Main, Germany , Greifswald, Germany , Hamburg, Germany , Heidelberg, Germany , Jena, Germany , Leipzig, Germany , München, Germany , Münster, Germany , Tübingen, Germany and 1 more location